NO20022142D0 - Use of dopamine-D3 receptor agonists for the treatment of salt-dependent hypertension - Google Patents

Use of dopamine-D3 receptor agonists for the treatment of salt-dependent hypertension

Info

Publication number
NO20022142D0
NO20022142D0 NO20022142A NO20022142A NO20022142D0 NO 20022142 D0 NO20022142 D0 NO 20022142D0 NO 20022142 A NO20022142 A NO 20022142A NO 20022142 A NO20022142 A NO 20022142A NO 20022142 D0 NO20022142 D0 NO 20022142D0
Authority
NO
Norway
Prior art keywords
dopamine
salt
treatment
receptor agonists
dependent hypertension
Prior art date
Application number
NO20022142A
Other languages
Norwegian (no)
Other versions
NO20022142L (en
Inventor
Bernd Muehlbauer
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Publication of NO20022142D0 publication Critical patent/NO20022142D0/en
Publication of NO20022142L publication Critical patent/NO20022142L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
NO20022142A 1999-11-04 2002-05-03 Use of dopamine-D3 receptor agonists for the treatment of salt-dependent hypertension NO20022142L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19953254 1999-11-04
PCT/EP2000/010770 WO2001032263A1 (en) 1999-11-04 2000-10-31 Use of dopamine-d3 receptor agonists for the therapy of salt-dependent hypertension

Publications (2)

Publication Number Publication Date
NO20022142D0 true NO20022142D0 (en) 2002-05-03
NO20022142L NO20022142L (en) 2002-05-03

Family

ID=7928007

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022142A NO20022142L (en) 1999-11-04 2002-05-03 Use of dopamine-D3 receptor agonists for the treatment of salt-dependent hypertension

Country Status (15)

Country Link
EP (1) EP1233815A1 (en)
JP (1) JP2003513053A (en)
KR (1) KR20020062300A (en)
CN (1) CN1387450A (en)
AU (1) AU1390801A (en)
BR (1) BR0015310A (en)
CA (1) CA2389643A1 (en)
CZ (1) CZ20021521A3 (en)
HU (1) HUP0203024A2 (en)
IL (1) IL149266A0 (en)
MX (1) MXPA02004103A (en)
NO (1) NO20022142L (en)
RU (1) RU2002114818A (en)
WO (1) WO2001032263A1 (en)
ZA (1) ZA200204455B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1180599A1 (en) * 2000-08-16 2002-02-20 Siemens Building Technologies AG Safeguarding device for a pump, which can be used in a fluid transmission
JP2010184889A (en) * 2009-02-12 2010-08-26 Nihon Univ Medicine for preventing and treating hypertension
CA2777358A1 (en) 2009-10-16 2011-04-21 Epiomed Therapeutics, Inc. Emesis treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0817767B1 (en) * 1995-03-27 2000-05-24 Smithkline Beecham Plc Bicyclic amine derivatives and their use as anti-psychotic agents
FR2742149B1 (en) * 1995-12-11 1998-02-13 Inst Nat Sante Rech Med NOVEL 2-NAPHTAMIDE DERIVATIVES AND THEIR THERAPEUTIC APPLICATIONS

Also Published As

Publication number Publication date
HUP0203024A2 (en) 2003-02-28
JP2003513053A (en) 2003-04-08
ZA200204455B (en) 2003-09-04
WO2001032263A1 (en) 2001-05-10
CZ20021521A3 (en) 2003-05-14
KR20020062300A (en) 2002-07-25
NO20022142L (en) 2002-05-03
CN1387450A (en) 2002-12-25
EP1233815A1 (en) 2002-08-28
BR0015310A (en) 2002-07-09
RU2002114818A (en) 2004-01-10
IL149266A0 (en) 2002-11-10
CA2389643A1 (en) 2001-05-10
AU1390801A (en) 2001-05-14
MXPA02004103A (en) 2003-08-20

Similar Documents

Publication Publication Date Title
NO20022925D0 (en) EP4 receptor selective agonists for the treatment of osteoporosis
NO20032360D0 (en) EP4 receptor selective agonists for the treatment of osteoporosis
PT1189916E (en) N-PYRAZOLE AGONISTS OF THE A2A RECEPTOR
NO20014379L (en) Use of Xenon for the Treatment of Neurointoxics
NO20022105D0 (en) Positive modulators of nicotine receptor agonists
NO20030213D0 (en) Use of D2 / D3 receptor agonists for the treatment of fibromyalgia
DK1144395T3 (en) 2-amino-benzoxazinone derivatives for the treatment of obesity
NO20034122D0 (en) Amalgamated pyridine derivatives for use as vanilloid receptor antagonists for the treatment of pain
DK1446379T3 (en) Arylanilin-beta2-adrenergic receptor agonists
NO20013369D0 (en) Arylpiperazinyl-cyclohexyl-indole derivatives for the treatment of depression
NO20013381D0 (en) 2-oxybenzoxazinone derivatives for the treatment of obesity
NO20016246L (en) Selective iGluR5 receptor antagonist for the treatment of migraine
NO20020574D0 (en) Substituted 1,5-dihydropyrrole-2-derivatives which act as NMDA receptor antagonists for the treatment of the pain state
DE60028368D1 (en) AGONISTS OF THE PEROXISOMA ACTIVATOR RESPONSIVE RECEPTOR
NO20013997L (en) Receptor
NO20032304D0 (en) Use of selective dopamine D4 receptor agonists for the treatment of sexual dysfunction
NO20022142D0 (en) Use of dopamine-D3 receptor agonists for the treatment of salt-dependent hypertension
NO20021295D0 (en) Nikotinsyreacetylcholin receptor
ID30056A (en) 5-HTIF AGONISTS
DE60023020T2 (en) POSITIVE MODULATORS OF NICOTINE RECEPTOR AGONISTS
ID30381A (en) USE OF ARILALKANOILPIRIDAZINA
NO20014904D0 (en) Procedure for biasing an anchor line
SE9904449D0 (en) Activator of the vanilloid receptor
TR199901524A3 (en) The release of melatonin in the endogenous phase.
DK1200402T3 (en) Substituted 1,5-dihydropyrrol-2-one derivatives acting as NMDA receptor antagonists for the treatment of pain conditions

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application